Soft Market Testing - Pharmacy Aseptic Services Joint Venture
Description: University Hospitals Plymouth NHS Trust (UHP) is exploring options for the development of a new Pharmacy Aseptic Services suite. The proposed facility is intended to provide a comprehensive range of aseptic services including: Chemotherapy preparation Centralised Intravenous Additive Services (CIVAS) Outpatient Antimicrobial Therapy (OPAT/OPIT) support Clinical Trials aseptic support Future-proofed capacity for expected demand growth As part of this appraisal, the Trust is considering a range of potential delivery and funding models, including the possibility of forming a Joint Venture or other partnership with the private sector. The purpose of this soft market testing exercise is to understand: The level of interest from suppliers and investors in partnering with the Trust The range of commercial, technical, and operational models available in the market Key risks, dependencies, and proposed (read more...)
Summary: The University Hospitals Plymouth NHS Trust is entering the planning stage of a procurement process titled "Soft Market Testing – Pharmacy Aseptic Services Joint Venture". The focus is on developing a new suite for Pharmacy Aseptic Services, addressing needs such as chemotherapy preparation and outpatient antimicrobial therapy. In the context of this planning phase, the Trust is actively engaging in a preliminary market consultation to explore potential partnership models with private sector entities. An engagement event is scheduled for 4 February 2026 at the Trust's location in Plymouth, UK. Interested parties are invited to contribute insights, which will guide the Trust's future procurement strategy. This project falls under the services category, dealing primarily with pharmaceuticals and medical services, and is an initiative above the threshold, indicating significant scope and investment.